Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 1, 1998, Pages 121-127

  Sauer, Rolf ^a,b   Birkenhake, Stefan ^a   Kühn, Reinhard ^a   Wittekind, Christian ^a   Schrott, Karl Michael ^a   Martus, Peter ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Bladder cancer; Bladder preservation; Carboplatin; Cisplatin; pT category; R status; Radiochemotherapy; Transurethral resection

Indexed keywords

CARBOPLATIN; CISPLATIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CONTROLLED STUDY; CYSTECTOMY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TRANSURETHRAL RESECTION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RADIATION-SENSITIZING AGENTS; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 0031985484     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00579-8     Document Type: Article

References (27)

1. Blandy J. P., England H. R., Evans S. J. W., Hope-Stone H. F., Mair G. M., Mantell B. S., Oliver R. T. T3 bladder cancer - The case for salvage cystectomy. Br. J. Urol. 52:1980;506-510.
2. Bloom H. J. G., Hendry W. F., Wallace D. M., Skeot R. G. Treatment of T3 bladder cancer Controlled trial of pre-operation radiotherapy and radical cystectomy versus radical radio-therapy . Br. J. Urol. 54:1982;136-151.
3. Chauvet B., Brewer J., Felix-Faire C., Davon J. L., Viecet P., Rebrul F. Combined radiation therapy and cisplatin for locally advanced carcinoma of the urinary bladder. Cancer. 72:1993;2213-2218.
4. Cervak J., Cufer T., Kragelj B., Zakotnik B., Stanonik M. Sequential transurethral surgery, multiple drug chemotherapy and radiation therapy for invasive bladder carcinoma Initial report . Int. J. Radiat. Biol. Phys. 25:1993;777-782.
5. Coppin C., Cospordarowicz M., Dixn P. Improved local control of invasive bladder cancer by consurrent cisplatin and preoperative or radical radiation. Proc. Am. Soc. Clin. Oncol. 11:1992;198-201.
6. De Neve W., Lybeert M. L., Goor C., Crommelin M. A., Ribot J. G. Radiotherapy for T2 and T3 carcinoma of the bladder the influence of overall treatment time . Radiother. Oncol. 36:1995;183-188.
7. Duncan W., Quilty W. The result of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother. Oncol. 7:1986;299-310.
8. Dunst J., Sauer R., Schrott K. M., Kühn R., Wittekind C., Altendorf-Hofmann A. Organ sparing treatment of advanced bladder cancer. A 10 year experience. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;261-266.
9. Dunst J. The significance of radiotherapy in a multidisciplinary treatment approach of bladder cancer. Strahlenther. Onkol. 167:1991;563-580.
10. Gospordarowicz M. K., Hawkins M. V., Rawlings G. A., Connolly J. C., Jewett M. A., Thomas G. M., Heman J. G., Garett P. S., Chua R., Duncan W. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder failure analysis . J. Urol. 142:1989;1448-1454.
11. Housset M., Maulard C., Chretien Y., Dufour B., Delanian S., Huart J., Colardelle F., Brunel P., Baillet F. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder a prospective study . J. Clin. Oncol. 11:1993;2150-2157.
12. Jung P., Jakse G. Bladder preservation in invasive locally confined bladder cancer. Onkologie. 19:1996;296-301.
13. Kachnic L. A., Kaufman D. S., Zietman A. I., Dallow K. C., Griffin P. P., Heney N. M., Althausen A. F., Shipley W. U. Selective bladder preservation by combined modality therapy for invasive bladder cancer. Int. J. Radiat. Biol. Phys. 32:(Suppl.):1995;271.
14. Mameghan H., Fisher R., Mameghan J., Brook S. Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int. J. Radiat. Biol. Phys. 31:1995;247-254.
15. Martus, P.; Birkenhake, S.; Sauer, R. Age correction of survival rates in oncological studies. Strahlenther. Onkol. 178(12): in press; 1997.
16. Pagano F., Bassi P., Galetti T. P. Results of contemporary radical cystectomy for invasive bladder cancer a clinicopathological study with emphasis on the inadequacy of the tumor, nodes and metastases classification . J. Urol. 145:1991;45-49.
17. Rebischung J. C., Vannetzel J. M., Fournier F. Cyclic concomitant chemoradiotherapy for invasive bladder cancer phase 2 study with organ preservation . Proc. Am. Soc. Clin. Oncol. 11:1992;208-214.
18. Rhagavan D., Shipley W. U., Garnick M. B., Russel P. M., Richie J. P. Biology and management of bladder cancer. N. Engl. J. Med. 322:1990;1129-1138.
19. Rotman M., Macchia R., Silverstein R. Treatment of advanced bladder cancer with irradiation and concomitant 5-fluorouracil infusion. Cancer. 59:1987;710-715.
20. Russel K. J., Boileau M. A., Higano C., Collins C., Russel A. H., Koh W., Coles B., Chopman W. H., Griffin T. W. Combined 5-fluorouracil and irradiation for transitional cell carcinoma or the urinary bladder. Int. J. Radiat. Biol. Phys. 19:1990;693-699.
21. Shipley W. U., Prout G. R., Einstein A. B., Coombs J., Wajsman Z., Soloway M. S., Englander L., Barton B. Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA. 258:1987;931-935.
22. Skinner D. G., Lieskovsky G. Management of invasive and high grade bladder cancer. Diagnosis and management of genitourinary cancer. 1988;295-302 Saunders, Philadelphia.
23. Stöckle M., Riedmüller H., Hohenfellner R. Radikale Zystektomie - oft zu spät? Therapieergebnisse der radikalen Zystektomie mit und ohne adjuvante oder induktive MVAC Behandlung. Hartung R., Hübner W., Kropp W. Urologische Beckenchirurgie. 1991;279-287 Springer Verlag, Berlin.
24. Tester W., Porter A., Asbell S., Coughlin C., Heaney J., Krall J., Martz K., Venner P., Hammond E. Combined modality program with possible organ preservation for invasive bladder carcinoma results of RTOG protocol 85-12 . Int. J. Radiat. Biol. Phys. 25:1993;783-790.
25. Whitmore W. F., Batata M. A., Thoneim M. A., Grabstald H., Unal A. Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. J. Urol. 139:1988;299A.
26. Wishnow K. I., Levinson A. K., Johnson D. E. Stage B (T2/3aN0) transitional cell carcinoma of the bladder highly curable by radical cystectomy. Urology. 39:1992;1-9.
27. Zietman A. L., Shipley W. U., Kaufman D. S. The combination of cisplatin based chemotherapy and radiation with treatment of muscle invading transitional cell cancer of the bladder. Int. J. Radiat. Biol. Phys. 27:1993;161-170.